NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy

by Rothan, H.A., Amini, E., Faraj, F.L., Golpich, M., Teoh, T.C., Gholami, K., Yusof, R.
Published 2017

Scalable production of recombinant membrane active peptides and its potential as a complementary adjunct to conventional chemotherapeutics

by Rothan, H.A., Ambikabothy, J., Abdulrahman, A.Y., Bahrani, H., Golpich, M., Amini, E., Rahman, N.A., Teoh, T.C., Mohamed, Z., Yusof, R.
Published 2017